Tag Archives: hematological malignancies

June, 2017

August, 2016

  • 1 August

    Jazz Enters Hematological Malignancies Licensing Deal with Pfenex

    DUBLIN and SAN DIEGO, July 28, 2016 /PRNewswire/ — Jazz Pharmaceuticals plc(Nasdaq: JAZZ) and Pfenex Inc. (NYSE MKT: PFNX) today announced an agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and commercialize multiple early stage hematology product candidates.  The agreement also includes an option for Jazz Pharmaceuticals …

October, 2015